Market Overview:
The global in vitro fertilization (IVF) market is expected to register a CAGR of 7.8% during the forecast period, 2018-2030. The market growth can be attributed to factors such as rising infertility rates, technological advancements in the field of IVF and increasing number of single women opting for fertility treatments. Based on type, the global IVF market is segmented into intrauterine insemination (IUI), intra cytoplasmic sperm injection (ICSI), drug and hormone therapies, and others. IUI accounted for the majority share of the global IVF market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its low cost and high success rate as compared to other treatment methods. Based on application, male infertility accounted for a major share of the global IVF market in 2017; however, female infertility is projected to grow at a higher CAGR during 2018-2030 owing to increasing awareness about available treatments among women across all regions studied herein.
Product Definition:
InVitro Fertilization (IVF) is a medical procedure in which an egg is fertilized by sperm outside the body. The fertilized egg, called an embryo, is then transferred to the woman's uterus to implant and grow. IVF may be used when a couple cannot conceive naturally because of problems with the woman's ovaries or fallopian tubes, or problems with the man's sperm.
Intrauterine Insemination (IUI):
Intrauterine insemination (IUI) is a fertility treatment that involves placing a spermicide between the uterus and the ovary. The spermicide blocks the cervix so that only one egg can join with one sperm to form an embryo. Intrauterine insemination is used as an alternative to IVF when patients have very poor response to clomiphene citrate or metformin therapy for infertility.
Intra Cytoplasmic Sperm Injection (ICSI):
Intra cytoplasmic sperm injection (ICSI) is a procedure used in the treatment of male infertility. It is also used in cases where the man has lost his fertility due to cancer treatments, or other conditions that have damaged the testicles.
Application Insights:
The male infertility segment dominated the global in vitro fertilization (IVF) market and accounted for 33.9% of the revenue share in 2017. The high share is attributable to factors such as rising number of patients suffering from low sperm count, poor quality of semen, andospermia or azoospermia. Moreover, advances in assisted reproductive technology have led to an increase in the number of IVF procedures performed for male infertility. For instance, a study reported by WHO analyzed data from 2016 and estimated that around 1 million men between 15-44 years suffer from some form of Male Infertility (MI).
On the other hand, female fertility problems are amongst one of the most common reasons leading people to seek IVF treatment worldwide.
Regional Analysis:
Europe dominated the global in vitro fertilization market with a share of over 40.0% in 2017 owing to the high incidence of infertility among women and men. The presence of supportive government bodies such as the European Society for Human Reproduction and Embryology (ESHRE) that promotes, supports, and conducts research related to human embryo development helps fertility clinics across Europe practice IVF procedures ethically without any restraint.
Asia Pacific is expected to grow at a lucrative rate during the forecast period due to rising awareness about available treatment options along with increasing government initiatives for creating awareness about IVF procedure s &rology clinics offering these services are encouraged by local governments which leads them having more patients thereby driving growth in this region. Moreover, an increase in international travel for medical reasons has led many people from developing countries like India seeking treatment at developed nations like U.K.
Growth Factors:
- Rising infertility rates among couples across the globe is expected to drive the demand for IVF services over the forecast period.
- Increasing number of single women and lesbian couples opting for fertility treatments is another key factor anticipated to propel growth of the market.
- Growing awareness about assisted reproductive technologies (ART) and their benefits is projected to boost adoption of IVF procedures in coming years.
- Technological advancements in ART procedures are likely to create new opportunities for market players over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
InVitro Fertilization (IVF) Market Research Report
By Type
Intrauterine Insemination (IUI), Intra Cytoplasmic Sperm Injection (ICSI), Drug and Hormone Therapies, Others
By Application
Male Infertility, Female Infertility
By Companies
Vitrolife AB, Merck Serono, Ferring Pharmaceuticals, Irvine Scientific, GeneaBiomedx, Cooper Surgical, Origio, Genea, Halotech Dna, Auxilium Pharmaceuticals, Auxogyn, Ovascience, Andrology Solutions
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
187
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global InVitro Fertilization (IVF) Market Report Segments:
The global InVitro Fertilization (IVF) market is segmented on the basis of:
Types
Intrauterine Insemination (IUI), Intra Cytoplasmic Sperm Injection (ICSI), Drug and Hormone Therapies, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Male Infertility, Female Infertility
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Vitrolife AB
- Merck Serono
- Ferring Pharmaceuticals
- Irvine Scientific
- GeneaBiomedx
- Cooper Surgical
- Origio
- Genea
- Halotech Dna
- Auxilium Pharmaceuticals
- Auxogyn
- Ovascience
- Andrology Solutions
Highlights of The InVitro Fertilization (IVF) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intrauterine Insemination (IUI)
- Intra Cytoplasmic Sperm Injection (ICSI)
- Drug and Hormone Therapies
- Others
- By Application:
- Male Infertility
- Female Infertility
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the InVitro Fertilization (IVF) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In vitro fertilization (IVF) is a fertility treatment that uses sperm and eggs from a donor to help a woman conceive. Doctors use assisted reproductive technologies, such as in-vitro fertilization (IVF), to help couples who are unable to conceive naturally. IVF involves the use of medications and techniques to stimulate the production of multiple eggs in the womanu2019s ovaries. The doctors then remove these eggs and freeze them for future use. They also extract sperm from male partners using various techniques, including intracytoplasmic sperm injection (ICSI). The doctors then combine these two samples in an attempt to create embryos that can be implanted into the womanu2019s uterus. If successful, this process can lead to pregnancy
Some of the major players in the invitro fertilization (ivf) market are Vitrolife AB, Merck Serono, Ferring Pharmaceuticals, Irvine Scientific, GeneaBiomedx, Cooper Surgical, Origio, Genea, Halotech Dna, Auxilium Pharmaceuticals, Auxogyn, Ovascience, Andrology Solutions.
The invitro fertilization (ivf) market is expected to register a CAGR of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 InVitro Fertilization (IVF) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 InVitro Fertilization (IVF) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 InVitro Fertilization (IVF) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the InVitro Fertilization (IVF) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global InVitro Fertilization (IVF) Market Size & Forecast, 2018-2028 4.5.1 InVitro Fertilization (IVF) Market Size and Y-o-Y Growth 4.5.2 InVitro Fertilization (IVF) Market Absolute $ Opportunity
Chapter 5 Global InVitro Fertilization (IVF) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 InVitro Fertilization (IVF) Market Size Forecast by Type
5.2.1 Intrauterine Insemination (IUI)
5.2.2 Intra Cytoplasmic Sperm Injection (ICSI)
5.2.3 Drug and Hormone Therapies
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global InVitro Fertilization (IVF) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 InVitro Fertilization (IVF) Market Size Forecast by Applications
6.2.1 Male Infertility
6.2.2 Female Infertility
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global InVitro Fertilization (IVF) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 InVitro Fertilization (IVF) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America InVitro Fertilization (IVF) Analysis and Forecast
9.1 Introduction
9.2 North America InVitro Fertilization (IVF) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America InVitro Fertilization (IVF) Market Size Forecast by Type
9.6.1 Intrauterine Insemination (IUI)
9.6.2 Intra Cytoplasmic Sperm Injection (ICSI)
9.6.3 Drug and Hormone Therapies
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America InVitro Fertilization (IVF) Market Size Forecast by Applications
9.10.1 Male Infertility
9.10.2 Female Infertility
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe InVitro Fertilization (IVF) Analysis and Forecast
10.1 Introduction
10.2 Europe InVitro Fertilization (IVF) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe InVitro Fertilization (IVF) Market Size Forecast by Type
10.6.1 Intrauterine Insemination (IUI)
10.6.2 Intra Cytoplasmic Sperm Injection (ICSI)
10.6.3 Drug and Hormone Therapies
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe InVitro Fertilization (IVF) Market Size Forecast by Applications
10.10.1 Male Infertility
10.10.2 Female Infertility
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific InVitro Fertilization (IVF) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific InVitro Fertilization (IVF) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific InVitro Fertilization (IVF) Market Size Forecast by Type
11.6.1 Intrauterine Insemination (IUI)
11.6.2 Intra Cytoplasmic Sperm Injection (ICSI)
11.6.3 Drug and Hormone Therapies
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific InVitro Fertilization (IVF) Market Size Forecast by Applications
11.10.1 Male Infertility
11.10.2 Female Infertility
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America InVitro Fertilization (IVF) Analysis and Forecast
12.1 Introduction
12.2 Latin America InVitro Fertilization (IVF) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America InVitro Fertilization (IVF) Market Size Forecast by Type
12.6.1 Intrauterine Insemination (IUI)
12.6.2 Intra Cytoplasmic Sperm Injection (ICSI)
12.6.3 Drug and Hormone Therapies
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America InVitro Fertilization (IVF) Market Size Forecast by Applications
12.10.1 Male Infertility
12.10.2 Female Infertility
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) InVitro Fertilization (IVF) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) InVitro Fertilization (IVF) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) InVitro Fertilization (IVF) Market Size Forecast by Type
13.6.1 Intrauterine Insemination (IUI)
13.6.2 Intra Cytoplasmic Sperm Injection (ICSI)
13.6.3 Drug and Hormone Therapies
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) InVitro Fertilization (IVF) Market Size Forecast by Applications
13.10.1 Male Infertility
13.10.2 Female Infertility
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 InVitro Fertilization (IVF) Market: Competitive Dashboard
14.2 Global InVitro Fertilization (IVF) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Vitrolife AB
14.3.2 Merck Serono
14.3.3 Ferring Pharmaceuticals
14.3.4 Irvine Scientific
14.3.5 GeneaBiomedx
14.3.6 Cooper Surgical
14.3.7 Origio
14.3.8 Genea
14.3.9 Halotech Dna
14.3.10 Auxilium Pharmaceuticals
14.3.11 Auxogyn
14.3.12 Ovascience
14.3.13 Andrology Solutions